Literature DB >> 25638400

Role of obesity and adipose tissue-derived cytokine leptin during Clostridium difficile infection.

Rajat Madan1, William A Petri2.   

Abstract

Obesity is among the most pressing health concerns in the world since it is increasingly common even in the developing world, and is clearly associated with increased risk for chronic debilitating diseases and death. Furthermore, obesity can influence the pathogenesis of infectious diseases by affecting the balance of pathogen clearance and pathological inflammation. The mechanisms that result in enhanced inflammation in obese individuals are poorly understood. Clostridium difficile is a major cause of nosocomial infections worldwide. Recent studies have shown that obesity is associated with increased risk of C. difficile infections. In this review, we will discuss our current knowledge of the role of obesity in determining risk of C. difficile infections, and focus on the role of the adipose tissue-derived cytokine leptin in C. difficile infections.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Adipocytokine; Clostridium difficile; Leptin; Obesity

Mesh:

Substances:

Year:  2015        PMID: 25638400      PMCID: PMC4492854          DOI: 10.1016/j.anaerobe.2014.12.009

Source DB:  PubMed          Journal:  Anaerobe        ISSN: 1075-9964            Impact factor:   3.331


  66 in total

1.  Impairment of host resistance to Listeria monocytogenes infection in liver of db/db and ob/ob mice.

Authors:  Shin Ikejima; Sanae Sasaki; Hiroshi Sashinami; Fumiaki Mori; Yoshiji Ogawa; Teruo Nakamura; Yoshinao Abe; Koichi Wakabayashi; Toshihiro Suda; Akio Nakane
Journal:  Diabetes       Date:  2005-01       Impact factor: 9.461

2.  Body-mass index and mortality among 1.46 million white adults.

Authors:  Amy Berrington de Gonzalez; Patricia Hartge; James R Cerhan; Alan J Flint; Lindsay Hannan; Robert J MacInnis; Steven C Moore; Geoffrey S Tobias; Hoda Anton-Culver; Laura Beane Freeman; W Lawrence Beeson; Sandra L Clipp; Dallas R English; Aaron R Folsom; D Michal Freedman; Graham Giles; Niclas Hakansson; Katherine D Henderson; Judith Hoffman-Bolton; Jane A Hoppin; Karen L Koenig; I-Min Lee; Martha S Linet; Yikyung Park; Gaia Pocobelli; Arthur Schatzkin; Howard D Sesso; Elisabete Weiderpass; Bradley J Willcox; Alicja Wolk; Anne Zeleniuch-Jacquotte; Walter C Willett; Michael J Thun
Journal:  N Engl J Med       Date:  2010-12-02       Impact factor: 91.245

3.  Pulmonary Mycobacterium tuberculosis infection in leptin-deficient ob/ob mice.

Authors:  Catharina W Wieland; Sandrine Florquin; Edward D Chan; Jaklien C Leemans; Sebastiaan Weijer; Annelies Verbon; Giamila Fantuzzi; Tom van der Poll
Journal:  Int Immunol       Date:  2005-09-01       Impact factor: 4.823

4.  Comparison of the burdens of hospital-onset, healthcare facility-associated Clostridium difficile Infection and of healthcare-associated infection due to methicillin-resistant Staphylococcus aureus in community hospitals.

Authors:  Becky A Miller; Luke F Chen; Daniel J Sexton; Deverick J Anderson
Journal:  Infect Control Hosp Epidemiol       Date:  2011-04       Impact factor: 3.254

5.  Leptin mediates Clostridium difficile toxin A-induced enteritis in mice.

Authors:  Andreas Mykoniatis; Pauline M Anton; Michael Wlk; Chi Chung Wang; Linda Ungsunan; Susann Blüher; Maria Venihaki; Simos Simeonidis; Jeff Zacks; Dezheng Zhao; Stavros Sougioultzis; Katia Karalis; Christos Mantzoros; Charalabos Pothoulakis
Journal:  Gastroenterology       Date:  2003-03       Impact factor: 22.682

Review 6.  Microbiota-mediated colonization resistance against intestinal pathogens.

Authors:  Charlie G Buffie; Eric G Pamer
Journal:  Nat Rev Immunol       Date:  2013-10-07       Impact factor: 53.106

7.  Obesity as a risk factor for Clostridium difficile infection.

Authors:  Jihad Bishara; Raymond Farah; Julnar Mograbi; Wissam Khalaila; Omar Abu-Elheja; Mahmud Mahamid; William Nseir
Journal:  Clin Infect Dis       Date:  2013-05-03       Impact factor: 9.079

8.  Reproducible community dynamics of the gastrointestinal microbiota following antibiotic perturbation.

Authors:  Dionysios A Antonopoulos; Susan M Huse; Hilary G Morrison; Thomas M Schmidt; Mitchell L Sogin; Vincent B Young
Journal:  Infect Immun       Date:  2009-03-23       Impact factor: 3.441

9.  Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression.

Authors:  G M Lord; G Matarese; J K Howard; R J Baker; S R Bloom; R I Lechler
Journal:  Nature       Date:  1998-08-27       Impact factor: 49.962

Review 10.  Leptin, leptin receptors, and the control of body weight.

Authors:  J M Friedman
Journal:  Nutr Rev       Date:  1998-02       Impact factor: 7.110

View more
  5 in total

1.  The Impact of Bariatric Surgery on Short Term Risk of Clostridium Difficile Admissions.

Authors:  Hisham Hussan; Emmanuel Ugbarugba; Michael T Bailey; Kyle Porter; Bradley Needleman; Sabrena Noria; Benjamin O'Donnell; Steven K Clinton
Journal:  Obes Surg       Date:  2018-07       Impact factor: 4.129

Review 2.  Neutrophil-mediated inflammation in the pathogenesis of Clostridium difficile infections.

Authors:  Shinsmon Jose; Rajat Madan
Journal:  Anaerobe       Date:  2016-04-05       Impact factor: 3.331

3.  Long-term Outcomes Following Multiply Recurrent Clostridioides difficile Infection and Fecal Microbiota Transplantation.

Authors:  Ghadeer K Dawwas; Colleen M Brensinger; Ravy K Vajravelu; Qufei Wu; Colleen R Kelly; Loren Laine; Gary D Wu; James D Lewis
Journal:  Clin Gastroenterol Hepatol       Date:  2020-12-08       Impact factor: 11.382

Review 4.  Adipocyte inflammation and pathogenesis of viral pneumonias: an overlooked contribution.

Authors:  Pablo C Alarcon; Michelle S M A Damen; Rajat Madan; George S Deepe; Paul Spearman; Sing Sing Way; Senad Divanovic
Journal:  Mucosal Immunol       Date:  2021-05-06       Impact factor: 7.313

5.  Obesity is not associated with adverse outcomes among hospitalized patients with Clostridioides difficile infection.

Authors:  Alyyah Malick; Ying Wang; Jordan Axelrad; Hojjat Salmasian; Daniel Freedberg
Journal:  Gut Pathog       Date:  2022-01-29       Impact factor: 4.181

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.